![]() | |
Names | |
---|---|
IUPAC name 1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | |
Other names Norlaudanosoline; Tetrahydroxypapaveroline | |
Identifiers | |
3D model (JSmol) | |
313061 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.158.898 |
EC Number |
|
KEGG | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C16H17NO4 | |
Molar mass | 287.315 g·mol−1 |
Hazards | |
GHS labelling: | |
![]() | |
Warning | |
H302 | |
P264, P270, P301+P317, P330, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Tetrahydropapaveroline, also known as norlaudanosoline, is a tetrahydroisoquinoline alkaloid. It is also classified as a benzylisoquinoline alkaloids. [1]
Tetrahydropapaveroline is relevant to brain pathologies. [2]
It can be formed in trace amounts in the brain by a condensation reaction of dopamine and dopaldehyde (a metabolite of dopamine). [2] [3]
It inhibits dopamine uptake within the cerebral cortex. [4]